Old Web
English
Sign In
Acemap
>
authorDetail
>
Steven D. Levin
Steven D. Levin
Biology
Medicine
Molecular biology
Dose-ranging study
CD28
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
“Switch” Transmembrane Immunomodulatory Proteins (TIPs) Consisting of High-Affinity PD-1 Extracellular Domains (PD-1 vIgDs) and Costimulatory Intracellular Domains Potently Enhance the Activity of TCR-Engineered T Cells
2018
Blood
Steven D. Levin
Hieu Nguyen
Joseph L. Kuijper
Rebecca P. Wu
Ryan Swanson
Stanford L. Peng
Show All
Source
Cite
Save
Citations (0)
Therapeutic Candidate Alpn-101, a Dual ICOS/CD28 Antagonist, Potently Suppresses Human/NSG Mouse Xenograft Graft Vs. Host Disease (GvHD) in a Dose Ranging Study and Reduces Disease Activity in a Mouse Model of Hemophagocytic Lymphohistiocytosis (HLH)
2018
Blood
Stacey R. Dillon
Katherine E Lewis
Katherine Verbist
Paige Tedrick
Sabrin Albeituni
Ryan Swanson
Lawrence Evans
Steven D. Levin
Mark W. Rixon
Stanford L. Peng
Kim E. Nichols
Kristine M. Swiderek
Show All
Source
Cite
Save
Citations (0)
S13.3 Expression of Tumor-Associated Ganglioside and its Expression Mechanism in IL-3 Independent NSF-60 Cells Introduced with IL-3 Gene
1993
Glycoconjugate Journal
Pui-wai Cheng
Steven D. Levin
Thomas F Boat
Show All
Source
Cite
Save
Citations (0)
1
map